|
Currently, China's drug circulation industry is undergoing profound policy adjustments and market transformations. A series of critical policies have not only reshaped the competitive landscape but also placed unprecedented higher demands on the efficiency, resilience, and compliance of pharma supply chain. Meanwhile, the wave of digital and intelligent technologies, represented by AI, big data and the IoT, is driving comprehensive transformation across pharma R&D, manufacturing and distribution. Against this dual backdrop, the core of pharma supply chain management has rapidly expanded from traditional cost and efficiency-oriented approach to a complex system that encompasses full-chain traceability, network optimization, resilience & agility, E2E visibility, global operations, and full lifecycle management. GPSCS2026 will focus on four major dimensions:"Regulatory Compliance, Resilience & Agility, Cost & Efficiency, and Digital Intelligent Transformation", and delve into the full-chain upgrade and optimization from clinical trials, commercialization, manufacturing to circulation & distribution. We will jointly dissect cutting-edge practices and future trends, providing key insights and action guidelines for enterprises to build sustainable competitive advantages. |
|
Company Type: Pharma/ Biotech Company Hospital / Distributor / Wholesale / Retail LSPs/ Cold Chain Transport Provider Software / System / Digital Solution Provider Logistics Equipment / Packaging Government/ Associations/ Industry Organization College/ Academic Institution Consulting Firm/ Industry Media Position Type: CEO / President / GM SVP / VP / Deputy GM Director (Head) of Supply Chain/ Logistics/ Procurement / Operation / Planning etc. (Pharma) Department Manager of Supply Chain/ Logistics/ Procurement / Operation / Planning etc. (Pharma) Director (Head) of Region/ Marketing/ Sales / BD / Pharma BU / Cold Chain BU (Vendor) Department Manager of Marketing / Sales / BD / Pharma BU / Cold Chain BU (Vendor) Expert / Partner / Consultant / Chief Editor |
![]() |
Speakers & Cooperation | Sponsors & Registration | Media Cooperation | ![]() |
|
| _________________ | _________________ | _________________ | |||
|
Mr. Damon Woo Tel: 86 21 6077 8889*606 Mob: 136 8194 8168 Email: damon.woo@knggroup.com.cn |
Mr. Jason Wang Tel: 86 21 6077 8889*602 Mob: 186 1630 5050 Email: jason.wang@knggroup.com.cn |
Ms. Daisy Li Tel: 86 21 6077 8889*601 Email: daisy.li@knggroup.cn |